DrugPatentWatch Database Preview
Details for Patent: 9,486,413
» See Plans and Pricing
Which drugs does patent 9,486,413 protect, and when does it expire?
Patent 9,486,413 protects HYSINGLA ER and is included in one NDA.
This patent has two hundred and twenty-four patent family members in forty-one countries.
Summary for Patent: 9,486,413
| Title: | Tamper resistant dosage forms |
| Abstract: | The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof. |
| Inventor(s): | McKenna; William H. (Yonkers, NY), Mannion; Richard O. (Furlong, PA), O'Donnell; Edward P. (Basking Ridge, NJ), Huang; Haiyong H. (Princeton, NJ) |
| Assignee: | PURDUE PHARMA L.P. (Stamford, CT) PURDUE PHARMACEUTICALS L.P. (Wilson, NC) |
| Application Number: | 14/729,675 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,486,413 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; Device; |
Drugs Protected by US Patent 9,486,413
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-001 | Nov 20, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| Purdue Pharma Lp | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-002 | Nov 20, 2014 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Purdue Pharma Lp | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-003 | Nov 20, 2014 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Purdue Pharma Lp | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-004 | Nov 20, 2014 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Purdue Pharma Lp | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-005 | Nov 20, 2014 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,486,413
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 2355 | Start Trial | |||
| Argentina | 062511 | Start Trial | |||
| Argentina | 103463 | Start Trial | |||
| Argentina | 109796 | Start Trial | |||
| Argentina | 109797 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
